Arca
Skip to content
Tools
Tools

Adrenergic receptor alpha-1

Family in Homo sapiens that 15 drugs act on.

  • Drugs that act on it: 15
  • Approved: 12
  • In phases 1 to 3: 3
  • Sponsors: 11
  • Genes: 3

Who is on it, and how far along

Every drug ChEMBL records acting on ADRA1A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 15

Approved12

  • Phenylephrine
  • Carvedilol
  • Tamsulosin
  • Midodrine
  • Terazosin
  • Prazosin
  • Doxazosin
  • Metaraminol
  • Trimipramine
  • Alfuzosin
  • Methoxamine
  • Sertindole

Phase 31

  • Bunazosin

Phase 22

  • Bucindolol
  • Isoxsuprine

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 10 of 15 act as: Adrenergic receptor alpha-1 antagonist; the rest name their own mechanism.
    PhenylephrineApprovedParagon BioteckSmall moleculeAgonistAdrenergic receptor alpha-1 agonist55
    CarvedilolApprovedGSKSmall moleculeAntagonist52
    TamsulosinApprovedSanofiSmall moleculeAntagonist43
    MidodrineBoxed warningApprovedTakeda Pharmaceuticals USASmall moleculeAgonistAdrenergic receptor alpha-1 agonist11
    TerazosinApprovedAbbott LaboratoriesSmall moleculeAntagonist10
    PrazosinApprovedPfizerSmall moleculeAntagonist5
    DoxazosinApprovedViatrisSmall moleculeAntagonist2
    MetaraminolApproved—Small moleculeAgonistAdrenergic receptor alpha-1 agonist1
    TrimipramineBoxed warningApprovedTeva Pharmaceutical IndustriesSmall moleculeAntagonist1
    AlfuzosinApprovedADVANZ PHARMASmall moleculeAgonistAdrenergic receptor alpha-1 agonist0
    MethoxamineApprovedGSKSmall moleculeAgonistAdrenergic receptor alpha-1 agonist0
    SertindoleWithdrawnApprovedH. Lundbeck A/SSmall moleculeAntagonist0
    BunazosinPhase 3—Small moleculeAntagonist2
    BucindololPhase 2ARCA Biopharma, Inc.Small moleculeAntagonist0
    IsoxsuprinePhase 2—Small moleculeAntagonist0

    Open trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 49 in all, from ClinicalTrials.gov.
    Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential HypertensionDoxazosinPhase 4Not yet recruitingChina National Center for Cardiovascular DiseasesNov 12, 2026
    OB VEGA-Phenylephrine vs Norepinephrine OutcomesPhenylephrinePhase 4Not yet recruitingWake Forest University Health SciencesOct 28, 2026
    ED90 of Norepinephrine and Phenylephrine Infusion in Patients of Advanced Maternal AgePhenylephrineNot applicableNot yet recruitingGeneral Hospital of Ningxia Medical UniversityOct 26, 2026
    EMG-Guided Versus Endoscopic-Catheter Botulinum Toxin Injection for Spasmodic DysphoniaPhenylephrineNot applicableNot yet recruitingChinese University of Hong KongOct 26, 2026
    The Effect of Acupuncture on Passing Ureteral StonesTamsulosinNot applicableRecruitingHitit UniversityOct 26, 2026
    "Anticipant"-TIPS After a First Portal-hypertension-related Complication in CirrhosisCarvedilolNot applicableNot yet recruitingUniversity Hospital, ToulouseOct 22, 2026
    Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic HyperplasiaTamsulosinPhase 3Not yet recruitingIl-Yang Pharm. Co., Ltd.Oct 13, 2026
    Assessing Trauma-related Links Between Affective and Metabolic SystemsPrazosinPhase 4Not yet recruitingVA Office of Research and DevelopmentOct 7, 2026
    Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial)TamsulosinPhase 4Not yet recruitingShanghai East HospitalSep 29, 2026
    ED50/ED90 of Phenylephrine Infusion for Preventing Spinal Anesthesia-Induced Hypotension: Supine vs Left-Tilt 15°PhenylephrinePhase 4Not yet recruitingPeking University People's HospitalSep 17, 2026
    Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic ObstructionTamsulosinPhase 4Active, not recruitingMansoura UniversitySep 11, 2026
    Superiority of Phenylephrine Versus Norepinephrine in Complex Spine Surgery (SPiNeS)PhenylephrinePhase 4RecruitingMayo ClinicSep 1, 2026
    Prospective Post Market Clinical Trial for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH.TamsulosinPhase 4Not yet recruitingZenflow, Inc.Sep 1, 2026
    Terazosin And Metabolic Engagement in Alzheimer's DiseaseTerazosinPhase 2Not yet recruitingQiang ZhangSep 1, 2026
    Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsTamsulosinPhase 4Not yet recruitingMohsen PouraziziAug 3, 2026
    Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsTamsulosinPhase 4Not yet recruitingMohsen PouraziziAug 3, 2026
    Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)PhenylephrineNot applicableRecruitingCase Comprehensive Cancer CenterJul 30, 2026
    Effects Of Scapulothoracic Intervention With Or Without Neural Mobilization In Patients With Cervico-BrachialgiaPhenylephrineNot applicableNot yet recruitingRiphah International UniversityJul 24, 2026
    Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPHTamsulosinNot applicableRecruitingAin Shams UniversityJul 23, 2026
    Daily Knee Sleeve Use Versus No Use in Older Adults With Chronic Knee PainPhenylephrineNot applicableRecruitingMargaret L Gourlay, MD, MPHJun 30, 2026
    Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in CirrhosisCarvedilolNot applicableNot yet recruitingWest China HospitalMay 14, 2026
    Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary SyndromeCarvedilolNot applicableNot yet recruitingSeoul National University HospitalMay 11, 2026
    Apixaban-PK Trial: Preventing Portal Hypertension Complications in CirrhosisCarvedilolPhase 4RecruitingAsian Institute Of Medical SciencesApr 9, 2026
    The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.CarvedilolPhase 4RecruitingZiekenhuis Oost-LimburgApr 7, 2026
    The Effect of Continuous Positive Airway Therapy on the Blood Pressure in Sleepy vs Non-sleepy Patients With Obstructive Sleep ApneaBunazosin—Active, not recruitingKing's College LondonMar 27, 2026
    Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis.Midodrine, CarvedilolNot applicableNot yet recruitingInstitute of Liver and Biliary Sciences, IndiaMar 12, 2026
    Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure.MidodrineNot applicableNot yet recruitingInstitute of Liver and Biliary Sciences, IndiaFeb 20, 2026
    Comparison of the Efficacy of Continuous Metaraminol Infusion Versus Continuous Norepinephrine Infusion for the Prevention of Hypotension During Cesarean Section Under Spinal Anaesthesia. A Randomised Controlled Trial.MetaraminolNot applicableNot yet recruitingAretaieion University HospitalJan 23, 2026
    Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic VaricesCarvedilolPhase 4Enrolling by invitationXijing HospitalJan 20, 2026
    TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal HypertensionCarvedilolPhase 2Not yet recruitingTongji HospitalJan 20, 2026
    Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialTrimipraminePhase 2RecruitingCentre Hospitalier Universitaire VaudoisDec 4, 2025
    Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral SclerosisTerazosinEarly phase 1RecruitingUniversity of IowaNov 4, 2025
    Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform TrialTerazosinPhase 3RecruitingUniversity College, LondonOct 3, 2025
    Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related SymptomsTerazosinPhase 3RecruitingPenang Hospital, MalaysiaMay 13, 2025
    Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic StrokeTerazosinPhase 3RecruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineMar 7, 2025
    Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Intracerebral HemorrhageTerazosinPhase 3Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineMar 7, 2025
    Management of Non-Organic Dysphonia in Adults.BunazosinNot applicableRecruitingSohag UniversityMar 4, 2025
    Brain Blood Vessel Responses to Changes in Blood FlowPrazosinPhase 2RecruitingUniversity of Wisconsin, MadisonOct 8, 2024
    Brain Blood Vessel Responses to Changes in Blood Flow: Younger CohortPrazosinPhase 2RecruitingUniversity of Wisconsin, MadisonOct 8, 2024
    Midodrine in Heart Failure With Reduced Ejection Fraction With HypotensionMidodrinePhase 2 / Phase 3RecruitingOttawa Heart Institute Research CorporationMay 8, 2024
    MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) TrialMidodrinePhase 2RecruitingMayo ClinicMar 20, 2024
    Treatment of Orthostatic Hypotension in SCIMidodrinePhase 4RecruitingJames J. Peters Veterans Affairs Medical CenterMay 3, 2023
    Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory AscitesMidodrine—Active, not recruitingPost Graduate Institute of Medical Education and Research, ChandigarhJan 26, 2023
    Paediatric Syncope in the Emergency DepartmentMidodrineNot applicableRecruitingDr. Victoria ClaydonSep 27, 2022
    Terazosin and Parkinson's Disease Extension StudyTerazosinPhase 2Active, not recruitingCedars-Sinai Medical CenterNov 5, 2021
    Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)MidodrinePhase 4RecruitingUniversity of AlbertaSep 28, 2021
    Terazosin for Dementia With Lewy BodiesTerazosinPhase 1 / Phase 2Not yet recruitingQiang ZhangFeb 18, 2021
    Alpha-1 Blockade for Alcohol Use Disorder (AUD)Doxazosin, PrazosinPhase 2Active, not recruitingBrown UniversityOct 23, 2019
    Predicting Responses to PTSD Treatment With Iris and Cardiovascular TestsPrazosinPhase 3Active, not recruitingVA Office of Research and DevelopmentMay 29, 2018

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2094251, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

    Esc

    Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.